A single-dose study of HP-6050
Phase 1
- Conditions
- Healthy adult
- Registration Number
- JPRN-jRCT2031220092
- Lead Sponsor
- Inakura Hiroshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
Healthy Japanese adult males and females aged >=18 and <40 years
- Body mass index (BMI) is >=18.5 and <25.0
Exclusion Criteria
- Subjects with vagal tone
- Subjects with current or history of serious cardiac, vascular, renal, hepatic, psychiatric/neurological, or metabolic diseases
- Subjects who received any drug within a week prior to application of the study drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetic parameters, adverse events
- Secondary Outcome Measures
Name Time Method Pharmacodynamics